BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 24139496)

  • 1. Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies.
    Nijman IJ; van Montfrans JM; Hoogstraat M; Boes ML; van de Corput L; Renner ED; van Zon P; van Lieshout S; Elferink MG; van der Burg M; Vermont CL; van der Zwaag B; Janson E; Cuppen E; Ploos van Amstel JK; van Gijn ME
    J Allergy Clin Immunol; 2014 Feb; 133(2):529-34. PubMed ID: 24139496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted NGS: A Cost-Effective Approach to Molecular Diagnosis of PIDs.
    Stoddard JL; Niemela JE; Fleisher TA; Rosenzweig SD
    Front Immunol; 2014; 5():531. PubMed ID: 25404929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies.
    Picard C; Fischer A
    Eur J Immunol; 2014 Oct; 44(10):2854-61. PubMed ID: 25154746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies.
    Cifaldi C; Brigida I; Barzaghi F; Zoccolillo M; Ferradini V; Petricone D; Cicalese MP; Lazarevic D; Cittaro D; Omrani M; Attardi E; Conti F; Scarselli A; Chiriaco M; Di Cesare S; Licciardi F; Davide M; Ferrua F; Canessa C; Pignata C; Giliani S; Ferrari S; Fousteri G; Barera G; Merli P; Palma P; Cesaro S; Gattorno M; Trizzino A; Moschese V; Chini L; Villa A; Azzari C; Finocchi A; Locatelli F; Rossi P; Sangiuolo F; Aiuti A; Cancrini C; Di Matteo G
    Front Immunol; 2019; 10():316. PubMed ID: 31031743
    [No Abstract]   [Full Text] [Related]  

  • 5. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
    Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next generation sequencing as a diagnostic tool in epileptic disorders.
    Lemke JR; Riesch E; Scheurenbrand T; Schubach M; Wilhelm C; Steiner I; Hansen J; Courage C; Gallati S; Bürki S; Strozzi S; Simonetti BG; Grunt S; Steinlin M; Alber M; Wolff M; Klopstock T; Prott EC; Lorenz R; Spaich C; Rona S; Lakshminarasimhan M; Kröll J; Dorn T; Krämer G; Synofzik M; Becker F; Weber YG; Lerche H; Böhm D; Biskup S
    Epilepsia; 2012 Aug; 53(8):1387-98. PubMed ID: 22612257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of next generation sequencing in clinical primary immunodeficiencies.
    Raje N; Soden S; Swanson D; Ciaccio CE; Kingsmore SF; Dinwiddie DL
    Curr Allergy Asthma Rep; 2014 Oct; 14(10):468. PubMed ID: 25149170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Array-based sequence capture and next-generation sequencing for the identification of primary immunodeficiencies.
    Ghosh S; Krux F; Binder V; Gombert M; Niehues T; Feyen O; Laws HJ; Borkhardt A;
    Scand J Immunol; 2012 Mar; 75(3):350-4. PubMed ID: 22017423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Yield of Next Generation Sequencing in Genetically Undiagnosed Patients with Primary Immunodeficiencies: a Systematic Review.
    Yska HAF; Elsink K; Kuijpers TW; Frederix GWJ; van Gijn ME; van Montfrans JM
    J Clin Immunol; 2019 Aug; 39(6):577-591. PubMed ID: 31250335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostics of primary immunodeficiency diseases: a sequencing capture approach.
    Moens LN; Falk-Sörqvist E; Asplund AC; Bernatowska E; Smith CI; Nilsson M
    PLoS One; 2014; 9(12):e114901. PubMed ID: 25502423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validation of targeted next-generation sequencing for inherited disorders.
    Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
    Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Customised molecular diagnosis of primary immune deficiency disorders in New Zealand: an efficient strategy for a small developed country.
    Ameratunga R; Woon ST
    N Z Med J; 2009 Oct; 122(1304):46-53. PubMed ID: 19859091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis of primary immunodeficiency diseases in a developing country: Iran as an example.
    Latif AH; Tabassomi F; Abolhassani H; Hammarström L
    Expert Rev Clin Immunol; 2014 Mar; 10(3):385-96. PubMed ID: 24450304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary immunodeficiencies.
    Notarangelo LD
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S182-94. PubMed ID: 20042228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary immunodeficiencies. Clinical features and variant forms].
    Fontán Casariego G
    Allergol Immunopathol (Madr); 2001; 29(3):101-7. PubMed ID: 11434882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform.
    Chan M; Ji SM; Yeo ZX; Gan L; Yap E; Yap YS; Ng R; Tan PH; Ho GH; Ang P; Lee AS
    J Mol Diagn; 2012 Nov; 14(6):602-12. PubMed ID: 22921312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution, clinical features and molecular analysis of primary immunodeficiency diseases in Chinese children: a single-center study from 2005 to 2011.
    Zhang ZY; An YF; Jiang LP; Liu W; Liu DW; Xie JW; Tang XM; Wang M; Yang XQ; Zhao XD
    Pediatr Infect Dis J; 2013 Oct; 32(10):1127-34. PubMed ID: 23673420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting.
    Hinchcliffe M; Le H; Fimmel A; Molloy L; Freeman L; Sullivan D; Trent RJ
    Pathology; 2014 Jan; 46(1):60-8. PubMed ID: 24300713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary immunodeficiency in south China: clinical features and a genetic subanalysis of 138 children.
    Zeng H; Tao Y; Chen X; Zeng P; Wang B; Wei R; Yao C; Xie Y; Li F; Tang Y; Cui Y; Sun G
    J Investig Allergol Clin Immunol; 2013; 23(5):302-8. PubMed ID: 24260974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.